World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects
Abstract
1. The World Medical Association (WMA) has developed the Declaration of Helsinki as a statement of ethical principles for medical research involving human subjects, including research on identifiable human material and data.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
AI-driven telemedicine and remote monitoring offer improved healthcare access to underserved or remote populations, addressing geographic disparities in healthcare delivery.
“AI-driven telemedicine and remote monitoring offer improved healthcare access to underserved or remote populations, addressing geographic disparities in healthcare delivery.[41]”
From Ethical implications of AI and robotics in healthcare: A review (2023) · cites this paper as [41]
All methods were performed in accordance with national and international guidelines and regulations, and with the Helsinki Declaration of 1975, as revised in 2013.
“All methods were performed in accordance with national and international guidelines and regulations, and with the Helsinki Declaration of 1975, as revised in 2013 [65].”
From Chemical Fingerprints of Emotional Body Odor (2020) · cites this paper as [65]
All procedures were conducted in accordance with the Helsinki Declaration of 1975, as updated in 2013.
“All procedures were conducted in accordance with the Helsinki Declaration of 1975, as updated in 2013. 27”
The trial was conducted in accordance with the Declaration of Helsinki, ICH-GCP, the German Drug Law, European regulations and applicable data protection laws.
“The trial was conducted in accordance with the Declaration of Helsinki [10], ICH-GCP, the German Drug Law (AMG), the European regulations Directive 2001/20/EC and Commission Directive 2005/28/EC and applicable data protection regulations and laws.”
From Pancreatic resection with perioperative drug repurposing of propranolol and etodolac – the phase II randomized controlled PROSPER trial (2025) · cites this paper as [10]
The study received approval from the Institutional Research Ethics Committee prior to data collection.
“This study followed the ethical principles of the Declaration of Helsinki (World Medical Association, 2013), with approval from the Institutional Research Ethics Committee of a private university prior to data collection.”
From Enhancing Student Success through AI-Assisted Reflective Learning in Entrepreneurship Education: An Empirical Study (2026) · cites this paper as World Medical Association, 2013
The study was approved by the Ethics Committee for Drug Research of the Salamanca Health Area and adhered to the Declaration of Helsinki.
“This trial received ethics approval from the Ethics Committee for Drug Research of the Salamanca Health Area (PI code 2023061317) on 13 June 2023. All study procedures adhered to the principles of the Declaration of Helsinki [16].”
From Efficacy of Power Training on Sarcopenic Obesity in Community-Dwelling Older Women: A 32-Week Randomized Clinical Trial (2025) · cites this paper as [16]
The study was conducted according to the Declaration of Helsinki with ethics committee approval and written informed consent.
“The data were collected according to the standards of the Declaration of Helsinki (World Medical Association, 2013), with the approval of the Ethics Committee for Research with Human Beings of the University of the Basque Country. Permits and written informed consents were requested from the school principals, parents and legal guardians, as well as from the students.”
From Risk factors for being a victim of online grooming in adolescents (2020) · cites this paper as World Medical Association, 2013
All procedures were in accordance with the ethical standards of the Helsinki Declaration.
“All procedures utilized in this study were in accordance with the ethical standards of the Helsinki Declaration of 1964 and subsequent amendments [21]”
From The Psychological Flexibility in Epilepsy Questionnaire (PFEQ): Psychometric properties of the Persian version (2022) · cites this paper as [21]
Videoconferencing is a promising approach to enhance accessibility for this population.
“The findings also support the use of videoconferencing as a promising approach to enhance accessibility, which is a key barrier to the provision of evidence-based treatments for this population.45”
From Effect of a Videoconference-Based Online Group Intervention for Traumatic Stress in Parents of Children With Life-threatening Illness (2020) · cites this paper as [45]
The present trial was implemented in compliance with the Declaration of Helsinki and good scientific practice.
“The present trial was implemented in compliance with the Declaration of Helsinki and good scientific practice [19].”
From Blended care in in-patient acute psychiatric care. The example of a group training for social competences in adults—A pretest–posttest feasibility study (2021) · cites this paper as [19]
The study was conducted in accordance with the Declaration of Helsinki.
“The study was conducted in accordance with the Declaration of Helsinki [21].”
From A pilot evaluation of a smartphone application for workplace depression (2020) · cites this paper as [21]
The statistical power of the analysis was 0.99.
“resulting in a statistical power (1 − β) = 0.99 [59].”
From Psychosocial Factors Predicting Resilience in Family Caregivers of Children with Cancer: A Cross-Sectional Study (2021) · cites this paper as [59]
All family caregivers were informed of the objectives and scope of the research and their rights according to the Declaration of Helsinki.
“All family caregivers were informed of the objectives and scope of the research and their rights according to the Declaration of Helsinki [59].”
From Psychosocial Factors Predicting Resilience in Family Caregivers of Children with Cancer: A Cross-Sectional Study (2021) · cites this paper as [59]
The study was conducted in accordance with the ethical principles of the Declaration of Helsinki and established guidelines for educational research.
“The study was conducted in accordance with the ethical principles of the Declaration of Helsinki and established guidelines for educational research [25].”
From Ethical engagement with artificial intelligence in faculty research education: evaluation of the New Knowledge Help (NKH) approach (2026) · cites this paper as [25]
The study was approved by the Research Ethics Board of the Second Affiliated Hospital of Wenzhou Medical University and conducted in accordance with the Declaration of Helsinki.
“The study was approved by the Research Ethics Board of the Second Affiliated Hospital of Wenzhou Medical University (2021-K-127-02) and conducted in accordance with the Declaration of Helsinki [11].”
From Identification of a Novel Non-Canonical Splice-Site Variant in ABCD1 (2023) · cites this paper as [11]
The uptake of ClinicalTrials.gov and ISRCTN was made possible by funded infrastructure from key organizations such as the US NIH, the European Commission, and the WHO, and their adoption was fostered by 2 decades of policies from the ICMJE, the Declaration of Helsinki, and the FDA.
“Their uptake was made possible by funded infrastructure from key organizations such as the US NIH, the European Commission, and the World Health Organization (WHO), and their adoption was fostered by 2 decades of policies from the International Committee of Medical Journal Editors [33], the Declaration of Helsinki [34], and the US Food and Drug Administration (FDA), among others.”
From Open Science 2.0: Towards a truly collaborative research ecosystem (2023) · cites this paper as [34]
By coupling these trackers with a decade of advocacy and multiple parliamentary inquiries, the UK is now a leader in clinical trials transparency, with results available for over 90% of trials of medicinal products under EU regulations.
“By coupling these trackers with a decade of advocacy and multiple parliamentary inquiries, the UK is now a leader in clinical trials transparency, with results available for over 90% of trials of medicinal products under EU regulations [34].”
From Open Science 2.0: Towards a truly collaborative research ecosystem (2023) · cites this paper as [34]
The study was conducted in accordance with the principles of the Declaration of Helsinki and International Council for Harmonisation Good Clinical Practice guidelines.
“The study was conducted in accordance with the principles of the Declaration of Helsinki and International Council for Harmonisation Good Clinical Practice guidelines (37, 38).”
From Efficacy and Safety of Adagrasib plus Cetuximab in Patients with <i>KRAS</i> G12C-Mutated Metastatic Colorectal Cancer (2024) · cites this paper as [38]
The study protocol was approved by the Ethics Committee of Baqiyatallah University of Medical Sciences under code IR.BMSU.REC.1394.145.
“The study protocol was reviewed and approved by the Ethics Committee of Baqiyatallah University of Medical Sciences, Tehran, Iran, under code IR.BMSU.REC.1394.145, in accordance with the Declaration of Helsinki of the World Medical Association [29].”
The Declaration of Helsinki states that biomedical research involving people should be based on thorough knowledge of scientific literature, as it is unethical to expose humans unnecessarily to risks of research.
“The World Medical Association’s Declaration of Helsinki states that biomedical research involving people should be based on a thorough knowledge of the scientific literature, as it is unethical to expose humans unnecessarily to the risks of research.2”
From SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials (2025) · cites this paper as [2]
It is generally agreed that trial sponsors and investigators have an ethical obligation to plan to provide care for participants' healthcare needs that arise as a direct consequence of participation in a trial.
“It is generally agreed that trial sponsors and investigators have an ethical obligation to plan to provide care for participants’ healthcare needs that arise as a direct consequence of participation in a trial.2 501 502”
From SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials (2025) · cites this paper as [2]
The study was approved by the Research Ethics Committees of the University of Granada and carried out with written informed consent from all subjects.
“This study was approved and carried out in accordance with the recommendations of the Research Ethics Committees of the University of Granada, with written informed consent from all subjects.”
From Training on Working Memory and Inhibitory Control in Young Adults (2016) · cites this paper as World Medical Association, 2013
Cited by
Sorted by citations
Cardiovascular implications of fatal outcomes of patients with Coronavirus Disease 2019 (COVID-19)
Guo, T., Fan, Y., Chen, M., Wu, X., Zhang, L., He, T., Wang, H., Wan, J., Wang, X., & Lu, Z. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1017 · Cited by 4,194 · see citing works
CONSORT 2010 statement: extension to randomised pilot and feasibility trials.
Eldridge, S. M., Chan, C. L., Campbell, M. J., Bond, C. M., Hopewell, S., Thabane, L., & Lancaster, G. A. (2016) · BMJ · doi:10.1136/bmj.i5239 · Cited by 3,404 · see citing works
Gorilla in our midst: An online behavioral experiment builder
Anwyl-Irvine, A. L., Massonnié, J., Flitton, A., Kirkham, N. Z., & Evershed, J. K. (2019) · Behavior Research Methods · doi:10.3758/s13428-019-01237-x · Cited by 1,878 · see citing works
Skrivankova, V. W., Richmond, R. C., Woolf, B. A. R., Davies, N. M., Swanson, S. A., VanderWeele, T. J., Timpson, N. J., Higgins, J. P. T., Dimou, N., Langenberg, C., et al. (2021) · BMJ · doi:10.1136/bmj.n2233 · Cited by 1,648 · see citing works
Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., Lingvay, I., Mosenzon, O., Rosenstock, J., Rubio, M. A., et al. (2021) · JAMA · doi:10.1001/jama.2021.3224 · Cited by 1,444 · see citing works
Villar, J., Ariff, S., Gunier, R. B., Thiruvengadam, R., Rauch, S. A., Kholin, K. A. M., Roggero, P., Prefumo, F., do Vale, M. S., Cardona–Pérez, J. A., et al. (2021) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2021.1050 · Cited by 1,340 · see citing works
Peterli, R., Wölnerhanssen, B. K., Peters, T., Vetter, D., Kröll, D., Borbély, Y., Schultes, B., Beglinger, C., Drewe, J., Schiesser, M., et al. (2018) · JAMA · doi:10.1001/jama.2017.20897 · Cited by 1,267 · see citing works
Spinner, C. D., Gottlieb, R., Criner, G. J., Arribas, J. R., Cattelan, A. M., Soriano, À., Ogbuagu, O. E., Malhotra, P., Mullane, K. M., Castagna, A., et al. (2020) · JAMA · doi:10.1001/jama.2020.16349 · Cited by 1,234 · see citing works
Villar, J., Ferrando, C., Martínez, D., Ambrós, A., Muñoz, T., Soler, J. A., Aguilar, G., Alba, F., González-Higueras, E., Conesa, L. A., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30417-5 · Cited by 1,241 · see citing works
Emicizumab Prophylaxis in Hemophilia A with Inhibitors
Oldenburg, J., Mahlangu, J. N., Kim, B. B., Schmitt, C., Callaghan, M. U., Young, G. A., Santagostino, E., Kruse‐Jarres, R., Négrier, C., Kessler, C. M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1703068 · Cited by 1,130 · see citing works
Adagrasib in Non–Small-Cell Lung Cancer Harboring a <i> KRAS <sup>G12C</sup> </i> Mutation
Jänne, P. A., Riely, G. J., Gadgeel, S. M., Heist, R. S., Ou, S.-H. I., Pacheco, J. M., Johnson, M. L., Sabari, J. K., Leventakos, K., Yau, E., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2204619 · Cited by 1,061 · see citing works
Reinert, T., Henriksen, T. V., Christensen, E., Sharma, S., Salari, R., Sethi, H., Knudsen, M., Nordentoft, I., Wu, H.-T., Tin, A. S., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.0528 · Cited by 1,011 · see citing works
Theelen, W. S. M. E., Peulen, H. M. U., Lalezari, F., van der Noort, V., de Vries, J. F., Aerts, J. G. J. V., Dumoulin, D. W., Bahce, I., Niemeijer, A.-L. N., de Langen, A. J., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.1478 · Cited by 1,020 · see citing works
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
Tilly, H., Morschhauser, F., Sehn, L. H., Friedberg, J. W., Trněný, M., Sharman, J. P., Herbaux, C., Burke, J. M., Matasar, M., Rai, S., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2115304 · Cited by 954 · see citing works
‘Hypernudge’: big Data as a mode of regulation by design
Yeung, K. (2017) · Information, Communication & Society · doi:10.1080/1369118x.2016.1186713 · Cited by 868 · see citing works
Venetoclax-Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
Seymour, J. F., Kipps, T. J., Eichhorst, B., Hillmen, P., D’Rozario, J., Assouline, S., Owen, C., Gerecitano, J., Robak, T., De la Serna, J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1713976 · Cited by 940 · see citing works
Watanabe, H., Domei, T., Morimoto, T., Natsuaki, M., Shiomi, H., Toyota, T., Ohya, M., Suwa, S., Takagi, K., Nanasato, M., et al. (2019) · JAMA · doi:10.1001/jama.2019.8145 · Cited by 874 · see citing works
HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma
Ahmed, N. M., Brawley, V. S., Hegde, M. G., Bielamowicz, K., Kalra, M., Landi, D. B., Robertson, C. S., Gray, T., Diouf, O., Wakefield, A., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.0184 · Cited by 851 · see citing works
Lapergue, B., Blanc, R., Gory, B., et al. (2017) · JAMA · doi:10.1001/jama.2017.9644 · Cited by 794 · see citing works
Daly, E. J., Trivedi, M. H., Janik, A., Li, H., Zhang, Y., Li, X., Lane, R., Lim, P., Duca, A. R., Hough, D., et al. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.1189 · Cited by 795 · see citing works
Pratley, R. E., Aroda, V. R., Lingvay, I., Lüdemann, J., Andreassen, C., Navarria, A., & Viljoen, A. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30024-x · Cited by 790 · see citing works
Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy
Gross, J. G., Glassman, A. R., Jampol, L. M., Inusah, S., Aiello, L. P., Antoszyk, A. N., Baker, C. W., Berger, B. B., Bressler, N. M., Browning, D. J., et al. (2015) · JAMA · doi:10.1001/jama.2015.15217 · Cited by 801 · see citing works
Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors
Mahlangu, J. N., Oldenburg, J., Paz‐Priel, I., Négrier, C., Niggli, M., Mancuso, M. E., Schmitt, C., Jiménez‐Yuste, V., Kempton, C. L., Dhalluin, C., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1803550 · Cited by 777 · see citing works
Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion
Jovin, T. G., Li, C., Wu, L., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2207576 · Cited by 737 · see citing works
Clinical Characteristics and Results of Semen Tests Among Men With Coronavirus Disease 2019
Li, D., Jin, M., Bao, P., Zhao, W., & Zhang, S. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.8292 · Cited by 745 · see citing works
Daly, E. J., Singh, J. B., Fedgchin, M., Cooper, K., Lim, P., Shelton, R. C., Thase, M. E., Winokur, A., Van Nueten, L., Manji, H., et al. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.3739 · Cited by 718 · see citing works
A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity
Kelly, A. S., Auerbach, P., Barrientos-Perez, M., Gies, I., Hale, P. M., Marcus, C., Mastrandrea, L. D., Prabhu, N., & Arslanian, S. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1916038 · Cited by 723 · see citing works
Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids
Gu, W., Deng, X., Lee, M., Sucu, Y., Arevalo, S., Stryke, D., Federman, S., Gopez, A., Reyes, K. R., Zorn, K. C., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1105-z · Cited by 707 · see citing works
Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer
Choi, I. J., Kook, M., Kim, Y., Cho, S., Lee, J. Y., Kim, C. G., Park, B., & Nam, B. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1708423 · Cited by 675 · see citing works
Brown, J. M., Campbell, J. P., Beers, A., Chang, K., Ostmo, S., Chan, R. V. P., Dy, J., Erdogmus, D., Ioannidis, S., Kalpathy-Cramer, J., et al. (2018) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2018.1934 · Cited by 657 · see citing works
Han, B., Li, K., Wang, Q., Zhang, L., Shi, J., Wang, Z., Cheng, Y., He, J., Shi, Y., Zhao, Y., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.3039 · Cited by 617 · see citing works
Khan, A., Benthin, C., Zeno, B. R., Albertson, T. E., Boyd, J. H., Christie, J. D., Hall, R., Poirier, G., Ronco, J. J., Tidswell, M., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1823-x · Cited by 600 · see citing works
Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression
Swindells, S., Andrade-Villanueva, J. F., Richmond, G. J., Rizzardini, G., Baumgarten, A., Masiá, M., Latiff, G., Pokrovsky, V. V., Bredeek, F., Smith, G. H. R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1904398 · Cited by 603 · see citing works
Gentilini, O., Botteri, E., Sangalli, C. A., et al. (2023) · JAMA Oncology · doi:10.1001/jamaoncol.2023.3759 · Cited by 575 · see citing works
Efficacy and safety of degludec versus glargine in type 2 diabetes.
Marso, S. P., McGuire, D. K., Zinman, B., Poulter, N. R., Emerson, S. S., Pieber, T. R., Pratley, R. E., Haahr, P.-M., Lange, M., Brown-Frandsen, K., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1615692 · Cited by 574 · see citing works
Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine
Dodick, D. W., Silberstein, S. D., BIGAL, M. E., Yeung, P. P., Goadsby, P. J., Blankenbiller, T., Grozinski‐Wolff, M., Yang, R., Ma, Y., & Aycardi, E. (2018) · JAMA · doi:10.1001/jama.2018.4853 · Cited by 563 · see citing works
Freitas, B. D. P., Dias, J. R. D. O., Prazeres, J. M. B., do Sacramento, G. A., Ko, A. I., Maia, M., & Belfort, R. (2016) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2016.0267 · Cited by 559 · see citing works
Xu, X.-F., Xing, H., Han, J., Li, Z.-L., Lau, W.-Y., Zhou, Y.-H., Gu, W.-M., Wang, H., Chen, T.-H., Zeng, Y.-Y., et al. (2019) · JAMA Surgery · doi:10.1001/jamasurg.2018.4334 · Cited by 532 · see citing works
COVID-19 Associated Pulmonary Aspergillosis
Koehler, P., Cornely, O. A., Böttiger, B. W., Dusse, F., Eichenauer, D. A., Fuchs, F., Hallek, M., Jung, N., Klein, F., Persigehl, T., et al. (2020) · Mycoses · doi:10.1111/myc.13096 · Cited by 547 · see citing works
Association between sleep duration and cognitive decline
Ma, Y., Liang, L., Zheng, F., Shi, L., Zhong, B., & Xie, W. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.13573 · Cited by 535 · see citing works
Simpson, E. L., Paller, A. S., Siegfried, E. C., Boguniewicz, M., Sher, L., Gooderham, M., Beck, L. A., Guttman‐Yassky, E., Pariser, D. M., Blauvelt, A., et al. (2019) · JAMA Dermatology · doi:10.1001/jamadermatol.2019.3336 · Cited by 532 · see citing works
Dealing with the positive publication bias: Why you should really publish your negative results
Mlinarić, A., Horvat, M., & Smolčić, V. Š. (2017) · Biochemia Medica · doi:10.11613/bm.2017.030201 · Cited by 546 · see citing works
Progression of Myopia in School-Aged Children After COVID-19 Home Confinement
Wang, J., Li, Y., Musch, D. C., Wei, N., Qi, X., Ding, G., Li, X., Li, J., Song, L., Zhang, Y., et al. (2021) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2020.6239 · Cited by 516 · see citing works
Zhu, A. X., Macarulla, T. M., Javle, M. M., Kelley, R. K., Lubner, S. J., Adeva, J., Cleary, J. M., Catenacci, D. V. T., Borad, M. J., Bridgewater, J. A., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.3836 · Cited by 524 · see citing works
UniMiB SHAR: A Dataset for Human Activity Recognition Using Acceleration Data from Smartphones
Micucci, D., Mobilio, M., & Napoletano, P. (2017) · Applied Sciences · doi:10.3390/app7101101 · Cited by 596 · see citing works
Isolation and characterization of extracellular vesicle subpopulations from tissues
Crescitelli, R., Lässer, C., & Lötvall, J. O. (2021) · Nature Protocols · doi:10.1038/s41596-020-00466-1 · Cited by 524 · see citing works
Blauvelt, A., Teixeira, H. D., Simpson, E. L., Costanzo, A., De Bruin-Weller, M., Barbarot, S., Prajapati, V. H., Lio, P., Hu, X., Wu, T., et al. (2021) · JAMA Dermatology · doi:10.1001/jamadermatol.2021.3023 · Cited by 516 · see citing works
Davies, M., Pieber, T. R., Hartoft-Nielsen, M.-L., Hansen, O. K. H., Jabbour, S., & Rosenstock, J. (2017) · JAMA · doi:10.1001/jama.2017.14752 · Cited by 506 · see citing works
Massarelli, E., William, W., Johnson, F., Kies, M., Ferrarotto, R., Guo, M., Feng, L., Lee, J. J., Tran, H., Kim, Y. U., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2018.4051 · Cited by 490 · see citing works
Bex, A., Mulders, P., Jewett, M. A. S., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.5543 · Cited by 497 · see citing works
Shah, M. A., Kojima, T., Hochhauser, D., Enzinger, P. C., Raimbourg, J., Hollebecque, A., Lordick, F., Kim, S., Tajika, M., Kim, H. T., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.5441 · Cited by 497 · see citing works
Lenze, E. J., Mattar, C., Zorumski, C. F., Stevens, A., Schweiger, J., Nicol, G. E., Miller, J. P., Yang, L., Yingling, M., Avidan, M. S., et al. (2020) · JAMA · doi:10.1001/jama.2020.22760 · Cited by 495 · see citing works
Martínez-Velilla, N., Casas-Herrero, A., Zambom-Ferraresi, F., Sáez de Asteasu, M. L., Lucia, A., Galbete, A., García-Baztán, A., Alonso-Renedo, J., González-Glaría, B., Gonzalo-Lázaro, M., et al. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.4869 · Cited by 481 · see citing works
Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism
Stott, D. J., Rodondi, N., Kearney, P. M., Ford, I., Westendorp, R. G. J., Mooijaart, S. P., Sattar, N., Aubert, C. E., Aujesky, D., Bauer, D. C., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1603825 · Cited by 490 · see citing works
Aroda, V. R., Rosenstock, J., Terauchi, Y., Altuntas, Y., Lalic, N. M., Morales Villegas, E. C., Jeppesen, O. K., Christiansen, E., Hertz, C. L., Haluzík, M., et al. (2019) · Diabetes Care · doi:10.2337/dc19-0749 · Cited by 493 · see citing works
Adams, J., Hillier-Brown, F. C., Moore, H. J., Lake, A. A., Araujo-Soares, V., White, M., & Summerbell, C. (2016) · Systematic Reviews · doi:10.1186/s13643-016-0337-y · Cited by 486 · see citing works
Shroff, R. T., Javle, M. M., Xiao, L., Kaseb, A. O., Varadhachary, G. R., Wolff, R. A., Raghav, K. P. S., Iwasaki, M., Masci, P., Ramanathan, R. K., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.0270 · Cited by 468 · see citing works
Geyer, C. E., Garber, J. E., Gelber, R. D., Yothers, G., Taboada, M., Ross, L., Rastogi, P., Cui, K. Y., Arahmani, A., Aktan, G., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.09.159 · Cited by 504 · see citing works
Bellan, M., Soddu, D., Balbo, P. E., Baricich, A., Zeppegno, P., Avanzi, G. C., Baldon, G., Bartolomei, G., Battaglia, M., Battistini, S., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.36142 · Cited by 468 · see citing works
Liau, L. M., Ashkan, K., Brem, S. S., Campian, J. L., Trusheim, J. E., IWAMOTO, F. M., Tran, D. D., Ansstas, G., Cobbs, C., Heth, J., et al. (2022) · JAMA Oncology · doi:10.1001/jamaoncol.2022.5370 · Cited by 471 · see citing works
Prognostic Value of Right Ventricular Longitudinal Strain in Patients With COVID-19
Li, Y., Li, H., Zhu, S., Xie, Y., Wang, B., He, L., Zhang, D., Zhang, Y., Yuan, H., Wu, C., et al. (2020) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.04.014 · Cited by 454 · see citing works
Using smartphones and health apps to change and manage health behaviors: a population-based survey
Ernsting, C., Dombrowski, S. U., Oedekoven, M., O´Sullivan, J. L., Kanzler, M., Kuhlmey, A., & Gellert, P. (2017) · Journal of Medical Internet Research · doi:10.2196/jmir.6838 · Cited by 400 · see citing works
Fleisher, A. S., Pontecorvo, M. J., Devous, M. D., Lu, M., Arora, A. K., Truocchio, S. P., Aldea, P., Flitter, M., Locascio, T., Devine, M., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.0528 · Cited by 448 · see citing works
Petersson, L., Larsson, I., Nygren, J. M., Nilsen, P., Neher, M., Reed, J. E., Tyskbo, D., & Svedberg, P. (2022) · BMC Health Services Research · doi:10.1186/s12913-022-08215-8 · Cited by 434 · see citing works
Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer
Disis, M. L., Taylor, M. H., Kelly, K. L., Beck, J. T., Gordon, M. S., Moore, K. M., Patel, M. R., Chaves, J. M., Park, H., Mita, A. C., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2018.6258 · Cited by 438 · see citing works
Association of office and ambulatory blood pressure with mortality and cardiovascular outcomes
Yang, W.-Y., Melgarejo, J. D., Thijs, L., Zhang, Z.-Y., Boggia, J., Wei, F.-F., Hansen, T. W., Asayama, K., Ohkubo, T., Jeppesen, J., et al. (2019) · JAMA · doi:10.1001/jama.2019.9811 · Cited by 491 · see citing works
Eggermont, A. M. M., Kiciński, M., Blank, C. U., Mandalà, M., Long, G. V., Atkinson, V. G., Dalle, S., Haydon, A. M., Khattak, A., Carlino, M. S., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2019.5570 · Cited by 440 · see citing works
Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation
Calkins, H. G., Willems, S., Gerstenfeld, E. P., Verma, A., SCHILLING, R. J., Hohnloser, S. H., Okumura, K., Serota, H., Nordaby, M., Guiver, K., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1701005 · Cited by 432 · see citing works
Cremolini, C., Rossini, D., Dell’Aquila, E., Lonardi, S., Conca, E., Del Re, M., Busico, A., Pietrantonio, F., Danesi, R., Aprile, G., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2018.5080 · Cited by 424 · see citing works
Capehorn, M. S., Catarig, A.-M., Furberg, J. K., Janez, A., Price, H. C., Tadayon, S., Vergès, B., & Marre, M. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.101117 · Cited by 412 · see citing works
Rosenstock, J., Allison, D., Birkenfeld, A. L., Blicher, T. M., Deenadayalan, S., Jacobsen, J. B., Serusclat, P., Violante, R., Watada, H., Davies, M., et al. (2019) · JAMA · doi:10.1001/jama.2019.2942 · Cited by 421 · see citing works
Li, J., Qin, S., Xu, R.-H., Shen, L., Xu, J., Bai, Y., Yang, L., Deng, Y., Chen, Z.-D., Zhong, H., et al. (2018) · JAMA · doi:10.1001/jama.2018.7855 · Cited by 425 · see citing works
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis
Bliddal, H., Bays, H., Czernichow, S., Uddén Hemmingsson, J., Hjelmesæth, J., Hoffmann Morville, T., Koroleva, A., Skov Neergaard, J., Vélez Sánchez, P., Wharton, S., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2403664 · Cited by 440 · see citing works
Rosenberg, R. P., Murphy, P., Zammit, G. K., Mayleben, D. W., Kumar, D., Dhadda, S., Filippov, G., LoPresti, A., & Moline, M. L. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.18254 · Cited by 418 · see citing works
Semaglutide added to basal insulin in type 2 diabetes (SUSTAIN 5): a randomized, controlled trial.
Rodbard, H. W., Lingvay, I., Reed, J., de la Rosa, R., Rose, L., Sugimoto, D., Araki, E., Chu, P.-L., Wijayasinghe, N., & Norwood, P. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00070 · Cited by 412 · see citing works
Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis
Silverberg, J. I., Simpson, E. L., Thyssen, J. P., Gooderham, M., Chan, G. L., Feeney, C., Biswas, P., Valdez, H., DiBonaventura, M., Nduaka, C. I., et al. (2020) · JAMA Dermatology · doi:10.1001/jamadermatol.2020.1406 · Cited by 413 · see citing works
Gross, J. G., Glassman, A. R., Liu, D., Sun, J. K., Antoszyk, A. N., Baker, C. W., Bressler, N. M., Elman, M. J., Ferris, F. L., Gardner, T. W., et al. (2018) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2018.3255 · Cited by 404 · see citing works
Biobanking in health care: evolution and future directions
Coppola, L., Cianflone, A., Grimaldi, A., Incoronato, M., Bevilacqua, P., Messina, F., Baselice, S., Soricelli, A., Mirabelli, P., & Salvatore, M. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1922-3 · Cited by 429 · see citing works
Perkins, G. D., Ji, C., Connolly, B. A., Couper, K., Lall, R., Baillie, J. K., Bradley, J. M., Dark, P. M., Dave, C., Soyza, A. D., et al. (2022) · JAMA · doi:10.1001/jama.2022.0028 · Cited by 396 · see citing works
Metabolic features of chronic fatigue syndrome
Naviaux, R. K., Naviaux, J. C., Li, K., Bright, A. T., Alaynick, W. A., Wang, L., Baxter, A., Nathan, N., Anderson, W. H., & Gordon, E. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607571113 · Cited by 393 · see citing works
Publication and other reporting biases in cognitive sciences: detection, prevalence, and prevention
Ioannidis, J. P. A., Munafò, M. R., Fusar-Poli, P., Nosek, B. A., & David, S. P. (2014) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2014.02.010 · Cited by 471 · see citing works
Hwang, T. S., Gao, S. S., Liu, L., et al. (2016) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2015.5658 · Cited by 391 · see citing works
Kemp, S. V., Slebos, D., Kirk, A. J. B., Kornaszewska, M., Carron, K., Ek, L., Broman, G., Hillerdal, G., Mal, H., Pison, C. M., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201707-1327oc · Cited by 392 · see citing works
Renú, A., Millán, M., Román, L. S., Blasco, J., Martí‐Fábregas, J., Terceño, M., Amaro, S., Serena, J. L., Urra, X., Laredo, C., et al. (2022) · JAMA · doi:10.1001/jama.2022.1645 · Cited by 393 · see citing works
Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
Chalmers, J. D., HAWORTH, C. S., Metersky, M. L., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2021713 · Cited by 379 · see citing works
Overton, E. T., Richmond, G. J., Rizzardini, G., Jaeger, H., Orrell, C., Идиятулловна, Н. Ф., Bredeek, F., Deltoro, M. G., Swindells, S., Andrade-Villanueva, J. F., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32666-0 · Cited by 380 · see citing works
Zinman, B., Bhosekar, V., Busch, R., Holst, I., Ludvik, B., Thielke, D., Thrasher, J., Woo, V., & Philis-Tsimikas, A. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30066-x · Cited by 376 · see citing works
Durbin, M. K., An, L., Shemonski, N. D., Soares, M., Santos, T., Lopes, M., Neves, C., & Cunha-Vaz, J. G. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.0080 · Cited by 373 · see citing works
Zarbock, A., Küllmar, M., Kindgen‐Milles, D., Wempe, C., Gerß, J., Brandenburger, T., Dimski, T., Tyczynski, B., Jahn, M., Mülling, N., et al. (2020) · JAMA · doi:10.1001/jama.2020.18618 · Cited by 379 · see citing works
Oaknin, A., Tinker, A. V., Gilbert, L., Samouëlian, V., Mathews, C. A., Brown, J., Barretina-Ginesta, M.-P., Moreno, V., Gravina, A., Abdeddaim, C., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.4515 · Cited by 373 · see citing works
Winkler, J. K., Fink, C., Toberer, F., Enk, A., Deinlein, T., Hofmann-Wellenhof, R., Thomas, L., Lallas, A., Blum, A., Stolz, W., et al. (2019) · JAMA Dermatology · doi:10.1001/jamadermatol.2019.1735 · Cited by 365 · see citing works
Patient involvement in clinical research: why, when, and how
Sacristán, J. A., Aguarón, A., Avendaño, C., Garrido, P., Carrion, J., Gutierrez, A., Kroes, R. A., & Flores, A. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s104259 · Cited by 363 · see citing works
Ethical implications of AI and robotics in healthcare: A review
Elendu, C., Amaechi, D. C., Elendu, T. C., Jingwa, K. A., Okoye, O. K., John Okah, M., Ladele, J. A., Farah, A. H., & Alimi, H. A. (2023) · Medicine · doi:10.1097/md.0000000000036671 · Cited by 370 · see citing works
Mullin, S., Smith, L., Lee, K., D'Souza, G., Woodgate, P. J. W., Elflein, J., Hällqvist, J., Toffoli, M., Streeter, A., Hosking, J., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2019.4611 · Cited by 360 · see citing works
Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3
Battisti, W. P., Wager, E., Baltzer, L., Bridges, D., Cairns, A., Carswell, C., Citrome, L., Gurr, J. A., Mooney, L. A., Moore, B., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0288 · Cited by 357 · see citing works
Tassorelli, C., Diener, H.-C., Dodick, D. W., Silberstein, S. D., Lipton, R. B., Ashina, M., Becker, W. J., Ferrari, M. D., Goadsby, P. J., Pozo-Rosich, P., et al. (2018) · Cephalalgia · doi:10.1177/0333102418758283 · Cited by 388 · see citing works
Bahr, R., Clarsen, B., Derman, W., Dvořák, J., Emery, C., Finch, C., Hägglund, M., Junge, A., Kemp, S., Khan, K., et al. (2020) · Orthopaedic Journal of Sports Medicine · doi:10.1177/2325967120902908 · Cited by 378 · see citing works
Ascierto, P. A., Long, G. V., Robert, C., Brady, B., Dutriaux, C., Di Giacomo, A. M., Mortier, L., Hassel, J. C., Rutkowski, P., McNeil, C., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2018.4514 · Cited by 352 · see citing works
Hochberg, M. C., Guermazi, A., Guehring, H., Aydemir, A., Wax, S. D., Fleuranceau-Morel, P., Bihlet, A. R., Byrjalsen, I., Andersen, J. R., & Eckstein, F. (2019) · JAMA · doi:10.1001/jama.2019.14735 · Cited by 355 · see citing works
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
Silverberg, J. I., Guttman‐Yassky, E., Thaçi, D., Irvine, A. D., Gold, L. S., Blauvelt, A., Simpson, E. L., Chu, C., Liu, Z., Lima, R. G., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2206714 · Cited by 363 · see citing works
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2013-11-27
- Volume
- 310
- Issue
- 20
- Pages
- 2191
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W4292528167
- Semantic Scholar
- 078c83b6dbc80b4d2bbb5d2015a86fa37bb15dbb
- Cited by
- 30,732
- References
- 0
- Citations by year
- 2026: 4682 · 2025: 4556 · 2024: 4336 · 2023: 3532 · 2022: 3468 · 2021: 2825 · 2020: 2195 · 2019: 1610 · 2018: 1294 · 2017: 926 · 2016: 672 · 2015: 410 · 2014: 186 · 2013: 11 · 2012: 2
- FWCI
- 434.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics and bioethics in healthcare
- Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
- Keywords
- Declaration of Helsinki, research ethics, human subjects research, ethical principles, informed consent, research data, World Medical Association
- MeSH terms
- Clinical Trials as Topic, Confidentiality, Helsinki Declaration, Humans, Human Experimentation, Informed Consent, Physicians, Placebos, Research Design, Risk Assessment, Ethics, Research, Vulnerable Populations
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review